The Biohacker's Longevity Stack
Comprehensive Longevity & Healthspan Extension
Anti-Aging & Longevity
Description
The ultimate longevity protocol combining telomerase activation, senescent cell clearance, mitochondrial optimization, immune rejuvenation, and NAD+ restoration for a multi-pathway approach to slowing biological aging.
🔬 How It Works
Epitalon activates telomerase to maintain telomere length — the molecular clock of aging. FOXO4-DRI selectively clears senescent ('zombie') cells that drive inflammaging. MOTS-c optimizes mitochondrial function and metabolic health. SS-31 directly targets mitochondrial inner membrane cardiolipin for bioenergetic restoration. Thymalin rejuvenates the thymus gland for immune system restoration. Humanin provides broad cytoprotective effects through anti-apoptotic signaling. NAD+ precursors restore the critical coenzyme that declines with age.
⚡ Synergy Explanation
This stack targets the seven pillars of aging simultaneously. Epitalon addresses telomere attrition — one of the primary hallmarks of aging. FOXO4-DRI clears the senescent cells that accumulate with age and poison surrounding tissue with inflammatory secretions. MOTS-c and SS-31 together restore mitochondrial function — MOTS-c from the metabolic signaling side and SS-31 by directly stabilizing the inner mitochondrial membrane. Thymalin reverses thymic involution, restoring the immune system's ability to produce naive T-cells. Humanin provides broad anti-apoptotic protection for neurons, cardiomyocytes, and other critical cells. NAD+ precursors restore the master metabolic coenzyme that activates sirtuins and PARPs for DNA repair and epigenetic maintenance. Together, they address: genomic instability, telomere attrition, cellular senescence, mitochondrial dysfunction, immunosenescence, and metabolic decline.
🧬 Peptides in This Stack
Epitalon
SubcutaneousTelomerase activator — maintains telomere length to slow cellular aging
FOXO4-DRI
Subcutaneous or intravenousSenolytic peptide — selectively induces apoptosis in senescent cells driving inflammaging
MOTS-c
SubcutaneousMitochondrial peptide — enhances metabolic function, insulin sensitivity, and exercise capacity
SS-31 (Elamipretide)
SubcutaneousMitochondrial inner membrane stabilizer — restores bioenergetics by targeting cardiolipin
Thymalin
SubcutaneousThymic peptide — rejuvenates immune function by restoring thymic output of naive T-cells
Humanin
SubcutaneousCytoprotective peptide — anti-apoptotic, neuroprotective, and cardioprotective signaling
NAD+ Precursors & Related Peptides
OralNAD+ restoration — replenishes the critical coenzyme for sirtuins, PARPs, and cellular energy
⏰ Timing & Administration
Duration: Cyclical — 10-14 day courses repeated 2-3x per year, with daily components ongoing
Time of Day: Epitalon evening (10-day course); FOXO4-DRI per protocol; MOTS-c morning 3x/week; SS-31 daily; Thymalin morning (10-day course); Humanin daily; NAD+ precursors morning
Notes: This is a comprehensive and advanced protocol requiring regular biomarker monitoring (telomere length, inflammatory markers, metabolic panels, immune cell counts). Components can be phased in over months. Work with a longevity-focused physician.
✅ Expected Results
- •Slowed biological aging as measured by epigenetic clocks
- •Maintained or improved telomere length
- •Improved immune function and reduced immunosenescence
- •Enhanced mitochondrial function and cellular energy
- •Reduced systemic inflammation (lower CRP, IL-6)
- •Improved metabolic markers (glucose, insulin, lipids)
- •Better cognitive function and neuroprotection
- •Improved skin quality and tissue resilience
⚠️ Warnings & Precautions
- ⚠ADVANCED PROTOCOL — requires physician oversight and regular comprehensive bloodwork
- ⚠FOXO4-DRI is highly experimental with very limited human data
- ⚠Senolytic therapy should be done in defined courses, not continuously
- ⚠Monitor for immune changes — thymic restoration can alter immune dynamics
- ⚠Some components are expensive and difficult to source with verified purity
- ⚠Long-term safety data for most components in this combination is lacking
- ⚠Not recommended for those with active cancer — growth-promoting peptides are contraindicated